Risk Factors Associated with the Development and Progression of Chronic Kidney Disease in Patients Attending UMF 35
Downloads
Objective: To analyze the modifiable risk factors associated with the onset and progression of chronic kidney disease in patients at UMF 35.
Materials and Methods: An analytical, prospective, observational, and cross-sectional study was conducted. Data were collected using a researcher-designed instrument specifically developed for this study. Descriptive statistics were used for qualitative variables, including absolute frequencies and percentages. Pearson’s chi-square (χ²) test was applied, considering a statistically significant difference at p < 0.005.
Results: A total of 280 patients were included; 149 (53.2%) were women, with a mean age of 70.34 years. A statistically significant correlation was found between abdominal circumference and a glomerular filtration rate of less than 30 mL/min/1.73 m², with an incidence of 42 out of 121 cases and a relative risk (RR) of 1.393 (95% CI: 1.055–1.838).
rgaiz ER, Morales-Juárez L, Razo C, Ong L, Rafferty Q, Rincón-Pedrero R, et al. Renal pathophysiology and pharmacological mechanisms of nephroprotection. Med Fam SEMERGEN. 2023;49(Suppl 1):S1–S10.
doi:10.1016/j.semerg.2023.102021. Ardila R.
Spagnolo A, Puccio E, Spagnolo A. Kidney disease associated with metabolic syndrome. Rev Nefrol Dial Traspl. 2009;29(4):169–172.
Conroy-Ferreccio G. Biases in body mass index measurement in older adults. Nutr Hosp. 2017;34(1):251. doi:10.20960/nh.1002.
Oscanoa-Espinoza T, Lizaraso-Soto F. Nonsteroidal anti-inflammatory drugs: gastrointestinal, cardiovascular, and renal safety. Rev Gastroenterol Peru. 2015;35(1):63–71.
Moreno González MI. Waist circumference: an important and useful measurement of cardiometabolic risk. Rev Chil Cardiol. 2010;29(1):85–87.
doi:10.4067/S0718-85602010000100008.
Montenegro-Morales LP, Garduño-García JJ, López-Arriaga JA. Risk and lifestyle factors associated with chronic kidney disease. Rev Med Inst Mex Seguro Soc. 2020;58(3):305–316.
doi:10.24875/RMIMSS.M20000035.
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294–1304. doi:10.1001/jama.2019.14745.
Lorenzo V, López Gómez JM, editors. Nephrology Today. Spain: Nefrología al Día; ISSN 2659-2606. Available from: https://www.nefrologiaaldia.org/654
Argaiz ER, Morales-Juárez L, Razo C, Ong L, Rafferty Q, Rincón-Pedrero R, et al. Burden of chronic kidney disease in Mexico: data analysis based on the Global Burden of Disease 2021 study. Gac Med Mex. 2023;159(6):501–508. doi:10.24875/gmm.23000393.
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2024 Clinical Practice Guidelines for Chronic Kidney Disease (Spanish version). In: Lorenzo V, López Gómez JM, editors. Nephrology Today. Available from:
https://www.nefrologiaaldia.org/644
Prieto-Robayo E, Ramírez-Espinosa CM, Restrepo-Mesa KA, Rodríguez-Lozano LM. Chronic kidney disease at Hospital de Pamplona, Norte de Santander. Rev Med Risaralda. 2024;30(1). Epub 2024 Aug 17.
Rodríguez-Ramos F, Herrera-Miranda GL. Risk factors associated with chronic kidney disease. Medisur. 2022;20(1). Epub 2022 Feb 28.
Copyright (c) 2026 Mónica Daniela Mera-Zunún, Uriel Ventura- Soriano, Verónica -Ramírez- Contreras, Nadia Esmeralda Crisantos-Reyes
This work is licensed under a Creative Commons Attribution 4.0 International License.
All Content should be original and unpublished.
